Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -20.02-3.593.8626.35-4.60

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -20.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-20.02
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 -20.02
Negative
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹523.1 Cr 9.3% 24.6% -31% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹180,488.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,452.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,057.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,220.0 Cr -4.1% -3.8% -4.3% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

9.3%

24.6%

-31%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses